Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study
出版年份 2013 全文链接
标题
Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study
作者
关键词
mTOR activity, Hodgkin-lymphoma, Rapalogs, TMA, Hodgkin-lymphoma xenograft
出版物
BMC CANCER
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2013-05-22
DOI
10.1186/1471-2407-13-250
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directions
- (2012) C. Villarreal-Garza et al. ANNALS OF ONCOLOGY
- Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
- (2012) E. Seront et al. ANNALS OF ONCOLOGY
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- The mTOR Signalling Pathway in Human Cancer
- (2012) Helena Pópulo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma
- (2012) Shau-Hsuan Li et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Activity and complexes of mTOR in diffuse large B-cell lymphomas—a tissue microarray study
- (2012) Anna Sebestyén et al. MODERN PATHOLOGY
- Everolimus: Targeted Therapy on the Horizon for the Treatment of Breast Cancer
- (2012) Chad M. Barnett PHARMACOTHERAPY
- mTOR complex 2 signaling and functions
- (2011) Won Jun Oh et al. CELL CYCLE
- Emerging roles for mammalian target of rapamycin inhibitors in the treatment of solid tumors and hematological malignancies
- (2011) Nushmia Z. Khokhar et al. CURRENT OPINION IN ONCOLOGY
- Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project
- (2011) R. Marcos-Gragera et al. HAEMATOLOGICA
- Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
- (2011) Christian Steidl et al. JOURNAL OF CLINICAL ONCOLOGY
- Mammalian target of rapamycin as a target in hematological malignancies
- (2011) Kevin R. Kelly et al. Targeted Oncology
- Clinical activity of mammalian target of rapamycin inhibitors in solid tumors
- (2011) Yesid Alvarado et al. Targeted Oncology
- Targeting the PI3K/AKT/mTOR Pathway in Non-Hodgkin’s Lymphoma: Results, Biology, and Development Strategies
- (2011) Jonathan H. Schatz Current Oncology Reports
- Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
- (2010) Adam Jona et al. BLOOD REVIEWS
- Target of Rapamycin Signaling in Leukemia and Lymphoma
- (2010) C. Vu et al. CLINICAL CANCER RESEARCH
- Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies
- (2010) N Chapuis et al. LEUKEMIA
- Molecular circuits of solid tumors: prognostic and predictive tools for bedside use
- (2010) Charles Ferté et al. Nature Reviews Clinical Oncology
- A Phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graftversushost disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL)
- (2009) Michael A. Pulsipher et al. BRITISH JOURNAL OF HAEMATOLOGY
- Survival after Hodgkin lymphoma
- (2009) Olav Favier et al. CANCER
- Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer
- (2009) P. Gulhati et al. CLINICAL CANCER RESEARCH
- PTEN and the PI3-Kinase Pathway in Cancer
- (2008) Nader Chalhoub et al. Annual Review of Pathology-Mechanisms of Disease
- Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
- (2008) Bing-Hua Jiang et al. DRUG RESISTANCE UPDATES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now